Beijing, China -The Medical Imaging & Technology Alliance (MITA) and the Advanced Medical Technology Association (AdvaMed) yesterday concluded a series of successful activities aimed at reducing barriers to trade between China and the United States and harmonizing international standards for medical devices. The organizations participated in the U.S.-China Joint Commission on Commerce and Trade (JCCT) Pharmaceuticals and Medical Device Subgroup meeting and led a two-day standards workshop that provided China's State Food and Drug Administration (SFDA) and Chinese industry representatives with additional expertise on IEC 60601-1 third edition -- the internationally recognized standard for electrical medical equipment.
"MITA is pleased to be working closely with AdvaMed and its industry partners on efforts to help China transition to this comprehensive standard," said Gail Rodriguez, MITA executive director. "The enhanced certainties and efficiencies inherent in China's adoption of IEC 60601-1 third edition will yield significant benefits to patients and manufacturers."
Story Continues Below Advertisement
Bayer HealthCare Multi Vendor Service will repair your probe with the same precision and care you provide to your patients. Call us at 1-844-MVS-5100 (1-844-687-5100) or visit www.ri.bayer.com
"China's transition to the third edition will usher in a more collaborative era of medical standards, driven by safety and international progress in technology," said Ralph Ives, AdvaMed executive vice president for global strategy and analysis.
Working closely with the U.S. Department of Commerce and other industry partners, MITA and AdvaMed hosted a robust standards workshop on IEC 60601-1 third edition that featured industry experts and international consultants, including technical advisors, secretaries and leaders of related IEC and ISO technical committees and working groups. The purpose was to increase the Chinese government's familiarity with the standard and further expedite their transition process. To be fully representative of the global medical device industry, speakers came from North and South America, Europe and Asia.
Prior to the workshop, MITA and AdvaMed participated in the JCCT Pharmaceuticals and Medical Device Subgroup meeting, where AdvaMed led discussions on follow-up to its combination products workshop that took place in coordination with the April subgroup meeting in Shenzhen and the U.S. experience in regulating these cutting-edge therapies, which combine pharmaceutical and medical device components. At the meeting, SFDA officials expressed appreciation for the opportunity to exchange information on this challenging regulatory area and affirmed that the Chinese system has been modeled on international best practices.